Purple Biotech (PPBT) — Long-term Investment Intensity
Purple Biotech (PPBT) has a Long-term Investment Intensity of 0.3% as of September 2022. Long-term investments of $187.00K represent 0.3% of total assets of $58.54 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Explore how efficiently does Purple Biotech generate cash to assess how effectively this company generates cash.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Purple Biotech Long-term Investment Intensity (2021–2021)
This chart shows how Purple Biotech's Long-term Investment Intensity has evolved across 1 annual periods from 2021 to 2021. As of September 2022, the intensity stands at 0.3%, reflecting long-term investments of $187.00K against total assets of $58.54 Million USD. Explore PPBT cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Purple Biotech (2021–2021)
The table below presents the year-by-year Long-term Investment Intensity for Purple Biotech from 2021 to 2021, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see PPBT market cap overview.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2021 | 0.3% | $187.00K | $70.20 Million | — |